Email
Print
Diabetes Therapeutics Market - Forecast(2024 - 2030)
1. Diabetes Therapeutics Market - Overview
1.1 Definitions and Scope
2. Diabetes Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Diabetes Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Diabetes Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Diabetes Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Diabetes Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Diabetes Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Diabetes Therapeutics Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Injectables
8.3.1.1 Insulin
8.3.1.2 Glucagon-Like Peptide-1 Receptor Agonist
8.3.1.3 Amylinomimetic Drug
8.3.2 Oral-Antidiabetic Drug
8.3.2.1 Biguanides
8.3.2.2 Sulfonylurea
8.3.2.3 Thiazolidinediones
8.3.2.4 Alpha-Glucosidase Inhibitor
8.3.2.5 Dipeptidyl Peptidase Iv Inhibitor
8.3.2.6 Meglitinides
8.3.2.7 Sodium-Glucose Cotransporter-2 Inhibitor
9. Diabetes Therapeutics Market - By Type (Market Size -$Million / $Billion)
10. Diabetes Therapeutics - By Application (Market Size -$Million / $Billion)
11. Diabetes Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 Diabetes Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Diabetes Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Diabetes Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Diabetes Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Diabetes Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Diabetes Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Diabetes Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Diabetes Therapeutics Market - Key Company List by Country Premium
15. Diabetes Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astrazeneca Plc
15.3 Boehringer Ingelheim Gmbh
15.4 Eli Lilly And Company
15.5 Glaxosmithkline Plc
15.6 Johnson Johnson
15.7 Merck Co , Inc
15.8 Novartis Ag
15.9 Novo Nordisk
15.10 Sanofi S A
15.11 Takeda Pharmaceutical Company Limited
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Diabetes Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Diabetes Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Diabetes Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Diabetes Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Diabetes Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Diabetes Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Diabetes Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Diabetes Therapeutics Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Injectables
8.3.1.1 Insulin
8.3.1.2 Glucagon-Like Peptide-1 Receptor Agonist
8.3.1.3 Amylinomimetic Drug
8.3.2 Oral-Antidiabetic Drug
8.3.2.1 Biguanides
8.3.2.2 Sulfonylurea
8.3.2.3 Thiazolidinediones
8.3.2.4 Alpha-Glucosidase Inhibitor
8.3.2.5 Dipeptidyl Peptidase Iv Inhibitor
8.3.2.6 Meglitinides
8.3.2.7 Sodium-Glucose Cotransporter-2 Inhibitor
9. Diabetes Therapeutics Market - By Type (Market Size -$Million / $Billion)
10. Diabetes Therapeutics - By Application (Market Size -$Million / $Billion)
11. Diabetes Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 Diabetes Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Diabetes Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Diabetes Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Diabetes Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Diabetes Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Diabetes Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Diabetes Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Diabetes Therapeutics Market - Key Company List by Country Premium
15. Diabetes Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astrazeneca Plc
15.3 Boehringer Ingelheim Gmbh
15.4 Eli Lilly And Company
15.5 Glaxosmithkline Plc
15.6 Johnson Johnson
15.7 Merck Co , Inc
15.8 Novartis Ag
15.9 Novo Nordisk
15.10 Sanofi S A
15.11 Takeda Pharmaceutical Company Limited
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Diabetes Therapeutics Market - Appendix16.1 Abbreviations
16.2 Sources
17. Diabetes Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Global Diabetes Therapeutic Market, By Product Market 2023-2030 ($M)1.1 Injectables Market 2023-2030 ($M) - Global Industry Research
1.1.1 Insulin Market 2023-2030 ($M)
1.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 ($M)
1.1.3 Amylinomimetic Drug Market 2023-2030 ($M)
1.2 Oral-Antidiabetic Drug Market 2023-2030 ($M) - Global Industry Research
1.2.1 Biguanides Market 2023-2030 ($M)
1.2.2 Sulfonylurea Market 2023-2030 ($M)
1.2.3 Thiazolidinediones Market 2023-2030 ($M)
1.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 ($M)
1.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 ($M)
1.2.6 Meglitinides Market 2023-2030 ($M)
1.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 ($M)
2.Global Global Diabetes Therapeutic Market, By Product Market 2023-2030 (Volume/Units)
2.1 Injectables Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Insulin Market 2023-2030 (Volume/Units)
2.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 (Volume/Units)
2.1.3 Amylinomimetic Drug Market 2023-2030 (Volume/Units)
2.2 Oral-Antidiabetic Drug Market 2023-2030 (Volume/Units) - Global Industry Research
2.2.1 Biguanides Market 2023-2030 (Volume/Units)
2.2.2 Sulfonylurea Market 2023-2030 (Volume/Units)
2.2.3 Thiazolidinediones Market 2023-2030 (Volume/Units)
2.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 (Volume/Units)
2.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 (Volume/Units)
2.2.6 Meglitinides Market 2023-2030 (Volume/Units)
2.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 (Volume/Units)
3.North America Global Diabetes Therapeutic Market, By Product Market 2023-2030 ($M)
3.1 Injectables Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Insulin Market 2023-2030 ($M)
3.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 ($M)
3.1.3 Amylinomimetic Drug Market 2023-2030 ($M)
3.2 Oral-Antidiabetic Drug Market 2023-2030 ($M) - Regional Industry Research
3.2.1 Biguanides Market 2023-2030 ($M)
3.2.2 Sulfonylurea Market 2023-2030 ($M)
3.2.3 Thiazolidinediones Market 2023-2030 ($M)
3.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 ($M)
3.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 ($M)
3.2.6 Meglitinides Market 2023-2030 ($M)
3.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 ($M)
4.South America Global Diabetes Therapeutic Market, By Product Market 2023-2030 ($M)
4.1 Injectables Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Insulin Market 2023-2030 ($M)
4.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 ($M)
4.1.3 Amylinomimetic Drug Market 2023-2030 ($M)
4.2 Oral-Antidiabetic Drug Market 2023-2030 ($M) - Regional Industry Research
4.2.1 Biguanides Market 2023-2030 ($M)
4.2.2 Sulfonylurea Market 2023-2030 ($M)
4.2.3 Thiazolidinediones Market 2023-2030 ($M)
4.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 ($M)
4.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 ($M)
4.2.6 Meglitinides Market 2023-2030 ($M)
4.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 ($M)
5.Europe Global Diabetes Therapeutic Market, By Product Market 2023-2030 ($M)
5.1 Injectables Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Insulin Market 2023-2030 ($M)
5.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 ($M)
5.1.3 Amylinomimetic Drug Market 2023-2030 ($M)
5.2 Oral-Antidiabetic Drug Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Biguanides Market 2023-2030 ($M)
5.2.2 Sulfonylurea Market 2023-2030 ($M)
5.2.3 Thiazolidinediones Market 2023-2030 ($M)
5.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 ($M)
5.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 ($M)
5.2.6 Meglitinides Market 2023-2030 ($M)
5.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 ($M)
6.APAC Global Diabetes Therapeutic Market, By Product Market 2023-2030 ($M)
6.1 Injectables Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Insulin Market 2023-2030 ($M)
6.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 ($M)
6.1.3 Amylinomimetic Drug Market 2023-2030 ($M)
6.2 Oral-Antidiabetic Drug Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Biguanides Market 2023-2030 ($M)
6.2.2 Sulfonylurea Market 2023-2030 ($M)
6.2.3 Thiazolidinediones Market 2023-2030 ($M)
6.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 ($M)
6.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 ($M)
6.2.6 Meglitinides Market 2023-2030 ($M)
6.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 ($M)
7.MENA Global Diabetes Therapeutic Market, By Product Market 2023-2030 ($M)
7.1 Injectables Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Insulin Market 2023-2030 ($M)
7.1.2 Glucagon-Like Peptide-1 Receptor Agonist Market 2023-2030 ($M)
7.1.3 Amylinomimetic Drug Market 2023-2030 ($M)
7.2 Oral-Antidiabetic Drug Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Biguanides Market 2023-2030 ($M)
7.2.2 Sulfonylurea Market 2023-2030 ($M)
7.2.3 Thiazolidinediones Market 2023-2030 ($M)
7.2.4 Alpha-Glucosidase Inhibitor Market 2023-2030 ($M)
7.2.5 Dipeptidyl Peptidase Iv Inhibitor Market 2023-2030 ($M)
7.2.6 Meglitinides Market 2023-2030 ($M)
7.2.7 Sodium-Glucose Cotransporter-2 Inhibitor Market 2023-2030 ($M)
LIST OF FIGURES
1.US Diabetes Therapeutics Market Revenue, 2023-2030 ($M)2.Canada Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
10.UK Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
12.France Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
16.China Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
17.India Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa Diabetes Therapeutics Market Revenue, 2023-2030 ($M)
21.North America Diabetes Therapeutics By Application
22.South America Diabetes Therapeutics By Application
23.Europe Diabetes Therapeutics By Application
24.APAC Diabetes Therapeutics By Application
25.MENA Diabetes Therapeutics By Application
26.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Boehringer Ingelheim Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Novo Nordisk, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Takeda Pharmaceutical Company Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)